Company Filing History:
Years Active: 2020
Title: Laurence Moore - Innovator in Cancer Treatment
Introduction
Laurence Moore is a notable inventor based in Newton, MA (US), recognized for his contributions to cancer treatment through innovative pharmaceutical combinations. His work primarily focuses on antineoplastic therapies, which are crucial in the fight against various forms of cancer.
Latest Patents
Laurence Moore holds a patent for "Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272." This patent describes a combination of temsirolimus and trastuzumab for the treatment of cancer. Additionally, it includes combinations of temsirolimus and HKI-272, as well as trastuzumab and HKI-272. The patent outlines regimens and kits for the treatment of metastatic breast cancer, which contain trastuzumab, temsirolimus, and/or HKI-272, optionally combined with other anti-neoplastic agents or immune modulators. He has 1 patent to his name.
Career Highlights
Laurence Moore has made significant strides in the pharmaceutical industry, particularly while working at Wyeth. His innovative approaches to cancer treatment have positioned him as a key figure in the development of effective therapies.
Collaborations
Throughout his career, Laurence has collaborated with esteemed colleagues, including Charles Zacharchuk and Sridhar Krishna Rabindran. These partnerships have further enhanced the impact of his work in the field of oncology.
Conclusion
In summary, Laurence Moore is a dedicated inventor whose work in cancer treatment has led to significant advancements in antineoplastic therapies. His innovative patent and collaborations reflect his commitment to improving patient outcomes in oncology.